Investment · Biotech
Jetstream Venture Fund invests in Rejuvenation Technologies
The company will expand operations and research on targeted mRNA therapies for severe age-related disease.
Funding the preclinical research operation
Rejuvenation Technologies received an investment from Jetstream Venture Fund. The amount was not disclosed.
The company will use the capital to expand operations and research and development. Its preclinical pipeline includes programmes for idiopathic pulmonary fibrosis and severe chronic liver disease, using targeted mRNA delivery to pursue temporary telomere extension.
Use of funds
Expand operations and research and development.
Funding history
Investment · This roundUndisclosed